Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
Clinical trial NCT02802163 · WITHDRAWN
Trial details
- NCT number
- NCT02802163
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2020-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.